// App-Quantinova.ai

: Long-Term (1-Year) Seizure Freedom with Adjunctive Perampanel in Pediatric Patients (Aged 4–<12 Years) with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS): Post Hoc Analysis of Study 311

Researchers

Presenter

  • Robert Flamini

Principal Investigators

  • Anna Patten

  • Manoj Malhotra

  • Leock Y Ngo

Medical Centers

  • Pediatric and Adolescent Neurodevelopmental Associates, Atlanta, GA, USA

  • Eisai Ltd., Hatfield, Hertfordshire, UK

  • Eisai Inc, Woodcliff Lake, NJ

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Epilepsy

Biomarkers

  • N/A

Drug/Treatment

  • Perampanel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved